| Autor: |
Cima LN; Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania., Lambrescu IM; Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania.; Carol Davila University of Medicine and Pharmacy Bucharest Romania., Stejereanu L; Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania.; Carol Davila University of Medicine and Pharmacy Bucharest Romania., Colita A; Department of Pediatric Bone Marrow Transplantation Fundeni Hospital Bucharest Romania.; Pediatrics Carol Davila University of Medicine and Pharmacy Bucharest Romania., Or R; Department of Bone Marrow Transplantation Cancer Immunotherapy & Immunobiology Research Center Hadassah University Hospital Jerusalem Israel.; Hematology Hadassah Hebrew University Medical Center Jerusalem Israel., Fica S; Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania.; Department of Endocrinology, Diabetes and Metabolic Disorders Elias University Hospital Bucharest Romania. |
| Jazyk: |
angličtina |
| Zdroj: |
Clinical case reports [Clin Case Rep] 2018 Mar 12; Vol. 6 (5), pp. 867-870. Date of Electronic Publication: 2018 Mar 12 (Print Publication: 2018). |
| DOI: |
10.1002/ccr3.1486 |
| Abstrakt: |
A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves' orbitopathy after alemtuzumab conditioning for hematopoietic stem cell transplantation. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
